Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma.
Journal: Blood advances
Published: April 13, 2020
Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer.
Journal: Clinical lung cancer
Published: June 19, 2016
Showing 1-2 of 2
Last Updated: 09/26/2026